SUBLOCADE

This brand name is authorized in United States. It is also authorized in Australia, Canada, Israel, New Zealand.

Active ingredients

The drug SUBLOCADE contains one active pharmaceutical ingredient (API):

1	Buprenorphine UNII 40D3SCR4GZ - BUPRENORPHINE
	Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.
	Read more about Buprenorphine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SUBLOCADE Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07BC01	Buprenorphine	N Nervous system → N07 Other nervous system drugs → N07B Drugs used in addictive disorders → N07BC Drugs used in opioid dependence
Discover more medicines within N07BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11987X, 11990C
CA	Health Products and Food Branch	02483084, 02483092
IL	מִשְׂרַד הַבְּרִיאוּת	8629, 8630
NZ	Medicines and Medical Devices Safety Authority	20364, 20390
US	FDA, National Drug Code	12496-0100, 12496-0300